210 related articles for article (PubMed ID: 32776461)
21. Safety and biocompatibility of carbohydrate-functionalized polyanhydride nanoparticles.
Vela-Ramirez JE; Goodman JT; Boggiatto PM; Roychoudhury R; Pohl NL; Hostetter JM; Wannemuehler MJ; Narasimhan B
AAPS J; 2015 Jan; 17(1):256-67. PubMed ID: 25421457
[TBL] [Abstract][Full Text] [Related]
22. Polyanhydride Nanoparticles Induce Low Inflammatory Dendritic Cell Activation Resulting in CD8
Darling R; Senapati S; Christiansen J; Liu L; Ramer-Tait AE; Narasimhan B; Wannemuehler M
Int J Nanomedicine; 2020; 15():6579-6592. PubMed ID: 32982219
[TBL] [Abstract][Full Text] [Related]
23. Hemagglutinin-based polyanhydride nanovaccines against H5N1 influenza elicit protective virus neutralizing titers and cell-mediated immunity.
Ross KA; Loyd H; Wu W; Huntimer L; Ahmed S; Sambol A; Broderick S; Flickinger Z; Rajan K; Bronich T; Mallapragada S; Wannemuehler MJ; Carpenter S; Narasimhan B
Int J Nanomedicine; 2015; 10():229-43. PubMed ID: 25565816
[TBL] [Abstract][Full Text] [Related]
24. High-throughput synthesis of carbohydrates and functionalization of polyanhydride nanoparticles.
Carrillo-Conde BR; Roychoudhury R; Chavez-Santoscoy AV; Narasimhan B; Pohl NL
J Vis Exp; 2012 Jul; (65):. PubMed ID: 22806007
[TBL] [Abstract][Full Text] [Related]
25. Automated High-Throughput Synthesis of Protein-Loaded Polyanhydride Nanoparticle Libraries.
Goodman JT; Mullis AS; Dunshee L; Mitra A; Narasimhan B
ACS Comb Sci; 2018 May; 20(5):298-307. PubMed ID: 29617113
[TBL] [Abstract][Full Text] [Related]
26. Surface engineered polyanhydride-based oral
Renu S; Markazi AD; Dhakal S; Lakshmanappa YS; Gourapura SR; Shanmugasundaram R; Senapati S; Narasimhan B; Selvaraj RK; Renukaradhya GJ
Int J Nanomedicine; 2018; 13():8195-8215. PubMed ID: 30555234
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles.
Hasibuzzaman MM; Ross KA; Salem AK; Narasimhan B; Simons AL
J Vis Exp; 2021 Jun; (172):. PubMed ID: 34251369
[TBL] [Abstract][Full Text] [Related]
28. Preparation and degradation behavior of polyanhydrides nanoparticles.
Lee WC; Chu IM
J Biomed Mater Res B Appl Biomater; 2008 Jan; 84(1):138-46. PubMed ID: 17474078
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and characterization of novel polyanhydrides with tailored erosion mechanisms.
Torres MP; Vogel BM; Narasimhan B; Mallapragada SK
J Biomed Mater Res A; 2006 Jan; 76(1):102-10. PubMed ID: 16138330
[TBL] [Abstract][Full Text] [Related]
30. Functionalization of polyanhydride microparticles with di-mannose influences uptake by and intracellular fate within dendritic cells.
Phanse Y; Carrillo-Conde BR; Ramer-Tait AE; Roychoudhury R; Pohl NL; Narasimhan B; Wannemuehler MJ; Bellaire BH
Acta Biomater; 2013 Nov; 9(11):8902-9. PubMed ID: 23796408
[TBL] [Abstract][Full Text] [Related]
31. Polymer chemistry influences monocytic uptake of polyanhydride nanospheres.
Ulery BD; Phanse Y; Sinha A; Wannemuehler MJ; Narasimhan B; Bellaire BH
Pharm Res; 2009 Mar; 26(3):683-90. PubMed ID: 18987960
[TBL] [Abstract][Full Text] [Related]
32. Polyanhydride microparticles enhance dendritic cell antigen presentation and activation.
Torres MP; Wilson-Welder JH; Lopac SK; Phanse Y; Carrillo-Conde B; Ramer-Tait AE; Bellaire BH; Wannemuehler MJ; Narasimhan B
Acta Biomater; 2011 Jul; 7(7):2857-64. PubMed ID: 21439412
[TBL] [Abstract][Full Text] [Related]
33. Recent Advances in Polyanhydride Based Biomaterials.
Basu A; Domb AJ
Adv Mater; 2018 Oct; 30(41):e1706815. PubMed ID: 29707879
[TBL] [Abstract][Full Text] [Related]
34. Antibody induction directed against the tumor-associated MUC4 glycoprotein.
Cai H; Palitzsch B; Hartmann S; Stergiou N; Kunz H; Schmitt E; Westerlind U
Chembiochem; 2015 Apr; 16(6):959-67. PubMed ID: 25755023
[TBL] [Abstract][Full Text] [Related]
35. Structural Stability and Antigenicity of Universal Equine H3N8 Hemagglutinin Trimer upon Release from Polyanhydride Nanoparticles and Pentablock Copolymer Hydrogels.
Siddoway AC; Verhoeven D; Ross KA; Wannemuehler MJ; Mallapragada SK; Narasimhan B
ACS Biomater Sci Eng; 2022 Jun; 8(6):2500-2507. PubMed ID: 35604784
[TBL] [Abstract][Full Text] [Related]
36. Single-dose combination nanovaccine induces both rapid and long-lived protection against pneumonic plague.
Wagner DA; Kelly SM; Petersen AC; Peroutka-Bigus N; Darling RJ; Bellaire BH; Wannemuehler MJ; Narasimhan B
Acta Biomater; 2019 Dec; 100():326-337. PubMed ID: 31610342
[TBL] [Abstract][Full Text] [Related]
37. Functionalization promotes pathogen-mimicking characteristics of polyanhydride nanoparticle adjuvants.
Phanse Y; Carrillo-Conde BR; Ramer-Tait AE; Roychoudhury R; Broderick S; Pohl N; Rajan K; Narasimhan B; Wannemuehler MJ; Bellaire BH
J Biomed Mater Res A; 2017 Oct; 105(10):2762-2771. PubMed ID: 28556563
[TBL] [Abstract][Full Text] [Related]
38. Design and synthesis of multifunctional gold nanoparticles bearing tumor-associated glycopeptide antigens as potential cancer vaccines.
Brinãs RP; Sundgren A; Sahoo P; Morey S; Rittenhouse-Olson K; Wilding GE; Deng W; Barchi JJ
Bioconjug Chem; 2012 Aug; 23(8):1513-23. PubMed ID: 22812418
[TBL] [Abstract][Full Text] [Related]
39. The role of microsphere fabrication methods on the stability and release kinetics of ovalbumin encapsulated in polyanhydride microspheres.
Determan AS; Graham JR; Pfeiffer KA; Narasimhan B
J Microencapsul; 2006 Dec; 23(8):832-43. PubMed ID: 17390625
[TBL] [Abstract][Full Text] [Related]
40. Combinatorial evaluation of in vivo distribution of polyanhydride particle-based platforms for vaccine delivery.
Petersen LK; Huntimer L; Walz K; Ramer-Tait A; Wannemuehler MJ; Narasimhan B
Int J Nanomedicine; 2013; 8():2213-25. PubMed ID: 23818778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
